Toronto, Ontario–(Newsfile Corp. – October 20, 2025) – Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, announces a proposed non brokered private placement. The Company intends to issue (the “Offering”) of up to 18,000,000 units (each, a “Unit”) at a […]
TORONTO–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, is pleased to announce that its Chief Operating Officer and Co-founder, Dr. Rahul Kushwah, will be presenting at the prestigious 25th MK Investment Conference in Munich, Germany, on October 1, 2025. The MK […]
Clinically validated SmartHealth AI Stations anchor expansion into Clinical-Trial Optimization and Consumer Digital Health, creating multiple recurring-revenue opportunities TORONTO-Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, today outlined a strategic plan to evolve from a single-product health-screening company into a diversified, […]
Adaptive “digital brain” designed to cut risk, cost and timelines in the $70-billion clinical-trials market1 Toronto, Ontario–(Newsfile Corp. – October 1, 2025) – Predictmedix AI Inc. (CSE: PMED) (OTC Pink: PMEDF) (FSE: 3QP0) (“Predictmedix” or the “Company”), an emerging leader in AI-powered health and safety technology, announced the launch of its Clinical-Trial AI Platform, an […]
TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED | OTC: PMEDF | FRA: 3QP), a leader in artificial intelligence-driven health screening solutions, is expanding into the direct-to-consumer market with a mobile solution designed to deliver rapid, non-invasive diabetic screening — with India identified as the initial launchpad for this transformative initiative. Leveraging the company’s proprietary AI technology, […]
TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leader in AI-powered health and safety technology, is proud to announce a high-impact strategic alliance with Pacific Mechatronics Pvt. Ltd., a premier systems integrator with deep-rooted access to Asia-Pacific’s defence, aerospace, and national security ecosystems. This collaboration marks a major […]
TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading provider in AI-driven health and safety solutions, is proud to announce its participation as one of four profiled companies in an exclusive European investor roadshow spanning Budapest (Hungary), Zagreb (Croatia), and Belgrade (Serbia) from May 17 to May 21, […]
TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading provider in AI-driven health and safety solutions, welcomes the U.S. Food and Drug Administration’s (FDA) groundbreaking move to phase out mandatory animal testing in drug development. As the pharmaceutical and biotech industries pivot toward more ethical and technologically advanced […]
TORONTO, April 07, 2025–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading provider in AI-driven health and safety solutions, proudly announces a significant milestone: its Smart Health AI Stations have successfully completed over 500,000 individual scans. This achievement highlights the scalability, precision, and real-world impact of Predictmedix AI’s […]
TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading provider in AI-powered health screening solutions, is pleased to announce the successful closing of the third and the final tranche of its non-brokered private placement, raising total gross proceeds of $100,000 CAD. Notably, $90,000 of the tranche was subscribed […]
TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), a leading provider in AI-powered health screening solutions, is pleased to announce the successful closing of the second tranche of its non-brokered private placement, raising total gross proceeds of $405,500. Notably, this tranche saw strong participation from two prominent German family […]
TORONTO–(BUSINESS WIRE)–Predictmedix AI Inc. (CSE: PMED) (OTC: PMEDF) (FRA: 3QP) (“Predictmedix” or the “Company”), an innovative provider of AI-powered health screening solutions, is pleased to announce that it is launching its enhanced Smart Health AI Stations across the United States, positioning itself to capitalize on the rapidly expanding population health management market. This strategic launch, […]
